AcelRx Pharma (ACRX) –
-
Form 4 TALPHERA, INC. For: Jan 22 Filed by: Harkey Wilmot B.
-
Form 4 TALPHERA, INC. For: Jan 22 Filed by: JAIN ABHINAV
-
Form 3 TALPHERA, INC. For: Jan 22 Filed by: JAIN ABHINAV
-
Form SC 13D TALPHERA, INC. Filed by: Nantahala Capital Management, LLC
-
Form 8-K TALPHERA, INC. For: Jan 17
-
Form 3 TALPHERA, INC. For: Jan 15 Filed by: Harkey Wilmot B.
-
Form 8-K TALPHERA, INC. For: Jan 12
-
Form 8-K TALPHERA, INC. For: Jan 09
-
AcelRx Pharma (ACRX) to Rebrand as Talphera, Inc
-
AcelRx Announces Rebranding With Name Change to Talphera, Inc.
-
Form 4 ACELRX PHARMACEUTICALS For: Dec 13 Filed by: Angotti Vincent J.
-
Form 4 ACELRX PHARMACEUTICALS For: Oct 10 Filed by: HOFFMAN STEPHEN J
-
Form 4 ACELRX PHARMACEUTICALS For: Oct 10 Filed by: Afable Richard
-
Form 4 ACELRX PHARMACEUTICALS For: Oct 10 Filed by: WAN MARK A
-
Form 4 ACELRX PHARMACEUTICALS For: Oct 10 Filed by: Bozilenko Marina
-
Form 4 ACELRX PHARMACEUTICALS For: Oct 10 Filed by: Broadfoot Jill Marie
-
Form 4 ACELRX PHARMACEUTICALS For: Oct 10 Filed by: Rosen Howard B
-
Form 4 ACELRX PHARMACEUTICALS For: Oct 10 Filed by: ADAMS ADRIAN
-
AcelRx Pharma (ACRX) Announces Publication of Study Evaluating Anticoagulation Practices for Continuous Renal Replacement Therapy in the US
-
AcelRx Pharmaceuticals Announces Publication of Study Evaluating Anticoagulation Practices for Continuous Renal Replacement Therapy in the United States
-
Form EFFECT ACELRX PHARMACEUTICALS
-
AcelRx Pharma (ACRX) Files $150M Mixed Shelf
-
Form S-3 ACELRX PHARMACEUTICALS
-
Form S-8 ACELRX PHARMACEUTICALS
-
Form 10-Q ACELRX PHARMACEUTICALS For: Sep 30
-
AcelRx Pharma (ACRX) Tops Q3 EPS by 20c
-
Form 8-K ACELRX PHARMACEUTICALS For: Nov 08
-
AcelRx Reports Third Quarter 2023 Financial Results and Provides Corporate Update
-
AcelRx to Host KOL Panel Discussion on Current Anticoagulant Use in Dialysis and the Upcoming Niyad™ Clinical Study
-
AcelRx to Host Third Quarter 2023 Financial Results Call and Webcast on November 8, 2023
-
AcelRx Pharma (ACRX) Receives Nasdaq Non-compliance Notice
-
Form 8-K ACELRX PHARMACEUTICALS For: Oct 18
-
Form 8-K ACELRX PHARMACEUTICALS For: Oct 10
-
Form DEFA14A ACELRX PHARMACEUTICALS
-
Form 8-K ACELRX PHARMACEUTICALS For: Oct 02
-
AcelRx Pharma (ACRX) Receives IDE Approval for Niyad and Advances to a Single Registration Study
-
AcelRx Receives IDE Approval for Niyad and Advances to a Single Registration Study
-
Alliance Global Partners Starts AcelRx Pharmaceuticals (ACRX) at Buy
-
AcelRx Pharmaceuticals (ACRX) PT Lowered to $5 at H.C. Wainwright
-
Form 8-K ACELRX PHARMACEUTICALS For: Sep 22
-
Form 4 ACELRX PHARMACEUTICALS For: Sep 11 Filed by: Angotti Vincent J.
-
AcelRx Pharmaceuticals to Participate in the H.C. Wainwright Annual Investment Conference
-
Form DEFA14A ACELRX PHARMACEUTICALS
-
Form DEF 14A ACELRX PHARMACEUTICALS For: Oct 10
-
Form 4 ACELRX PHARMACEUTICALS For: Aug 24 Filed by: Palmer Pamela P
-
Form 144 ACELRX PHARMACEUTICALS Filed by: Palmer Pamela P
-
Form 144 ACELRX PHARMACEUTICALS Filed by: Palmer Pamela P
-
H.C. Wainwright Upgrades AcelRx Pharmaceuticals (ACRX) to Buy
-
Form 10-Q ACELRX PHARMACEUTICALS For: Jun 30
-
Form 8-K ACELRX PHARMACEUTICALS For: Aug 10
Back to ACRX Stock Lookup